GGrantIndex
← Search

MOLECULARLY TARGETED RADIONUCLIDE THERAPY VIA THE INTEGRIN ALPHAVBETA6

$1,089,548FY2022Defense Health AgencyDOD

University Of California, Davis

Investigators

View source on USAspending →
MOLECULARLY TARGETED RADIONUCLIDE THERAPY VIA THE INTEGRIN ALPHAVBETA6 · GrantIndex